Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 22, 2024 06:56 ET | Source: Research and Markets

Comprehensive Insight on the Scleroderma Drug Pipeline Landscape Revealed in the Latest 2024 Report

Dublin, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The "Scleroderma - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The Scleroderma drug pipeline report for 2024 has...
November 01, 2024 05:14 ET | Source: Research and Markets

Scleroderma Diagnostics and Therapeutics Market Report 2024-2030: Rising Adoption of Immunosuppressive Drugs Bodes Well for Growth

Dublin, Nov. 01, 2024 (GLOBE NEWSWIRE) -- The "Scleroderma Diagnostics and Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global...
May 31, 2024 04:34 ET | Source: Research and Markets

Global Systemic Sclerosis (Scleroderma) Clinical Trials Review 2024: Clinical Trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status

Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Systemic Sclerosis (Scleroderma) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The...
August 01, 2023 05:53 ET | Source: Research and Markets

Global Scleroderma Drug Pipeline Research 2023: Comprehensive Insights About 45+ Companies and 50+ Pipeline Drugs

Dublin, Aug. 01, 2023 (GLOBE NEWSWIRE) -- The "Scleroderma - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's offering.This "Scleroderma- Pipeline Insight, 2023"...